Strikingly, PARPi treatment highly induced intracellular PD-L1 accumulation in both ovarian cancer-patient tumor samples and cell lines in vitro, prompting us to investigate the role of intracellular PD-L1 in promoting ovarian cancer progression. The gene discussed is CD274; the disease is neoplasm.